First use of intravenous chemotherapy cancer treatment: Rectifying the record

Journal of the American College of Surgeons

Volumn 212, Issue 3, 2011, Pages 413-417

  Fenn, John E ^a,b   Udelsman, Robert ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMETHINE; MUSTARD GAS;

ADULT; ANAMNESIS; AUTOPSY; CANCER THERAPY; CASE REPORT; HUMAN; LYMPHOMA; LYMPHOSARCOMA; MEDICAL RECORD; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TERMINAL DISEASE; VITAL SIGN; WAR;

EID: 79952316720     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2010.10.018     Document Type: Article

References (8)

1. Goodman LS,Wintrobe MM, Dameshek W, et al. Nitrogen mustard therapy: use of methyl-bis(beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. JAMA 1946;132:126-132.
2. Gilman A, Philips FS. The biological actions and therapeutic applications of the β- chloroethyl amines and sulfides. Science 1946;103:409-436.
3. Gilman A.The initial clinical trial of nitrogen mustard. Am J Surg 1963;105:574-578.
4. Urtz T. Time capsule: on the trail of a cancer cure. Yale-New Haven Hospital Magazine. Fall 1983.
5. Cooney G. Cancer chemotherapy from the battlefield to the laboratory to the bedside. Yale- New Haven Hospital Magazine. Winter 1992.
6. Lin J. From Chemical Terror to Clinical Trial: The Development of Chemotherapy at Yale in World War II. New Haven, CT: Yale University; 2009.
7. Altman LK. Dr Louis S Goodman, 94, chemotherapy pioneer, dies. The New York Times. November 28, 2000;Obituary.
8. Jacobs C. Henry Kaplan and the Story of Hodgkin's Disease. Stanford, CA: Stanford University Press; 2010.